Conference programme

A prominent investment banker provides an insider’s view of the financial, economic and business factors affecting the M&A market.

The panelists will discuss recent M&A developments and hot topics arising around the world.

The panel will focus on legal issues and developments in private equity dealmaking.

The healthcare/life sciences sector is one of the most active for M&A. Panellists will discuss a variety of related topics, including: strategic drivers; where the opportunities and risks lie; regulatory trends; and practical aspects of getting healthcare deals done.

Panelists will discuss trends including the role and perspectives of institutional investors, shareholder activism, ESG and stakeholderism, and the headwinds and tailwinds for sustainability and long-term investment, both in the U.S. and globally.

A discussion of the ever-evolving landscape of public M&A around the world, including recent developments in securities law.

The panelists will discuss significant antitrust/competition enforcement actions in the M&A context, developments in enforcement policy, and foreign direct investment and national security regimes around the world.

In-house counsel from important firms and institutions share their perspective on the most pressing issues they face, how they partner with outside counsel to resolve them and how they future-proof themselves.